Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1568853 | 0.89 | CNR2 (0.47) | BCHEACHEEGFRERBB2CNR2 | |
| SCHEMBL14755439 | 0.87 | CYP3A4 (0.44) | BCHEACHEMAPTMEN1KMT2A | |
| SCHEMBL1081206 | 0.85 | ALDH1A1 (0.49) | BCHEACHEEGFRMAPTLMNA | |
| SCHEMBL7024910 | 0.79 | GAA (0.46) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL10427974 | 0.76 | ALDH1A1 (0.48) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL7026099 | 0.76 | RECQL (0.44) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL28069216 | 0.76 | PNMT (0.43) | MAPTCA1 | |
| SCHEMBL2007289 | 0.75 | MEN1 (0.47) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL2006592 | 0.75 | MEN1 (0.47) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL1020042 | 0.73 | MAPK1 (0.39) | MAPTLMNAMEN1KMT2AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | BAYER CROPSCIENCE AG (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | BAYER CROPSCIENCE AG (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | NT5C, NT5E, NT5C3B | BCHE 1506/4885ACHE 1327/4885EGFR 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.